Haleon CEO Says 70% Of Cold And Flu Business Is Outside U.S.; Season Start Not Yet Seen In International Markets, Slightly Down To Date; China Centrum OTC Issue Not Expected To Have Solution In 2027; Working To Mitigate By Making Portfolio Changes In China; Doesn't Believe Company Has Pricing Issue, We Have Pricing Elasticities
CFO says supply chain productivity program expected to continue through H2; will cover on-cost seen in Middle EastIn Europe consumers seeking more value, using pantry stocks and leveraging more discretion particularly
Haleon's cold and flu business is mostly outside America, where the season hasn't started yet. The company is working on changes to handle challenges in China and keep costs down.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.